| Basic Medical Informatin |
| brand name |
| Razadyne, Razadyne Er, Reminyl, Nivalin |
Depakote |
| Treatment For |
| Mild To Moderate Dementia Caused By Alzheimer's Disease |
Various Types Of Seizure Disorders, Epilepsy |
| Legal Status |
| Rx-only |
Rx-only |
| Pregnancy cat. |
| B (us) |
D (us) |
| Possible Side Effects |
| Diarrhea; Dizziness; Headache; Indigestion; Loss Of Appetite; Mild Stomach Pain Or Upset; Nausea; Tiredness; Trouble Sleeping; Vomiting; Weight Loss. |
Weakness, Nausea And Vomiting, Diarrhea, Stomach Pain, Headache, Indigestion, Loss Of Appetite, Shaking Hands, Sleepiness Or Sleeplessness, Dizziness, Forgetfulness, Respiratory Infections, And Hair Loss |
| Precautions & Contraindications |
| Pregnant, Liver Or Kidney Problems, Heart Problems, Unexplained Fainting Episodes, Stomach Or Bowel Problems, Lung Or Breathing Problems, Copd, Or Urinary Blockage Or Trouble Urinating, Brain Lesions Or Tumors, Dementia |
Brain, Liver, Kidney Problems, Metabolic Disease, Blood Disease, Decrease In Albumin, Hiv Infection, Pregnancy And Breastfeeding |
| Excretion |
| Renal (95%, Of Which 32% Unchanged), Fecal (5%) |
|
| Storage Conditions |
| Room Temperature, In An Airtight Container. Keep Away From Children |
15-30°c |
|
| Dosage, Usage and Forms |
| Forms |
| Tablet, Capsule |
Tablet |
| Routes (of administration) |
| Oral |
Oral |
|
Dosage |
|
250 mg |
| Chemical Data |
| Bioavailability |
| 80-100% |
90 % |
| Protein binding |
| Hepatic, 18% |
|
| Metabolism |
| Hepatic Partially |
Liver |
| Half Life (hours) |
| 7 h |
8-15 H |
| Formula |
| C17h21no3 |
C16h31nao4 |
| Molecular mass (g/mol) |
| 287.354 G/mol |
310.405 G/mol |